InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by LeCointe-Cephas Lisa, VP Senior. Officer active across 1 company, notably Merck & Co., Inc.. In total, 9 disclosures have been logged. Activity tracked since 1 May 2021. The latest transaction was filed on 3 May 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
689 shares@ US$117.8917.5% of flowCommon StockSEC:0001127602-23-014745:0
643 shares@ US$115.4716.1% of flowCommon StockSEC:0001127602-23-014206:0
813 shares@ US$87.100.0000% mcap23.9% of flowCommon StockSEC:0001127602-22-013519:0
452 shares@ US$87.650.0000% mcap13.5% of flowCommon StockSEC:0001127602-22-013291:0
640 shares@ US$88.690.0000% mcap19.3% of flowCommon StockSEC:0001127602-22-013032:0
694 sharesCommon StockSEC:0001127602-21-015754
694 shares@ US$75.980.0000% mcap15.8% of flowCommon StockSEC:0001127602-21-015754:0
622 shares@ US$74.5013.7% of flowCommon StockSEC:0001127602-21-015279
622 shares@ US$74.500.0000% mcap13.7% of flowCommon StockSEC:0001127602-21-015279:0
9 of 9 declarations
About LeCointe-Cephas Lisa
Lisa LeCointe-Cephas is the SVP Chief Ethics & Compliance Officer at Merck & Co., Inc. She oversees the company's ethics and compliance programs, ensuring adherence to standards and regulations. Her role is essential in maintaining Merck's integrity and reputation.
